Bbr Partners, LLC Repligen Corp Transaction History

Bbr Partners, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $16 Million - $26.6 Million	-82,000 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $6.34 Million - $8.44 Million	-38,221 Reduced 31.79%	82,000 $16.4 Million
Q4 2020 Feb 16, 2021	SELL	$148.08 - $206.57 $3.85 Million - $5.37 Million	-26,000 Reduced 17.78%	120,221 $23 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $17.9 Million - $23.1 Million	146,221 New	146,221 $21.6 Million

477

54.9M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.66B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Bbr Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Bbr Partners, LLC with notifications on news.